In Conversation

“ At MVC we have chosen a tried and tested technology platform as novel vaccine technologies face novel challenges ”

“ We are confident that 2020 and 2021 will be very relevant years for regenerative medicine in Japan ”

“ We were the first Korean biotech to have independently developed, commercialized, marketed and exported an innovative drug ”

“ Despite the fact that I joined the company during the peak of the COVID-19 epidemic in China, we have achieved a number of milestones in the… ”

“ We believe, to make a meaningful impact on treatment, it is necessary to have more than one drug or regimen. We therefore see combination therapies as… ”

“ The greatest strength of Molcure’s system is the ability to discover drugs that could never be found by using conventional methods ”

“ There is growing interest from capital to invest in diagnostics companies. Within ten years, there is the possibility that this increased support and funding may help… ”

“ What is most important to stress is that there are many different applications for our technology, particularly in the field of regenerative medicine.  ”

“ Unmet medical needs in eye care are huge in the Asia markets, and biotech companies will become increasingly important players and innovation drivers in this area ”

“ Fundamentally, we are convinced that the China ophthalmology market is still a relatively blank slate with huge potential for innovative therapies and drugs, compared to the… ”

“ By now, we have a platform of over 500 billion small molecules, and in terms of published numbers, we probably have the largest DEL collections in… ”